Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

October 21, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the "LOI") to acquire TELI Pharmaceuticals, Inc., securing worldwide rights to its lead investigational therapy, Telomir-1.The transaction aligns Telomir's U.S. rights with...

Read more

CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"

October 21, 2025 7:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), through its wholly owned subsidiary CBD Vault, is proud to announce the official launch of its Mushroom-Infused Dubai Chocolate Bar, a premium fusion of functional wellness and luxury indulgence.Inspired by the decadent chocolate culture of Dubai, each bar combines pistachio-filled layers with rich, velvety chocolate and is infused with Cordyceps and Reishi mushroom extracts, two of the most powerful...

Read more

Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges

October 21, 2025 4:00 AM

Bioz, Inc., a pioneering AI platform changing the way companies present research-backed product evidence, is proud to announce a new partnership with Neutec Group. With the addition of Bioz Badges on their product webpages, and an innovative placement of Bioz Micro Badges within the website's navigation menu, Neutec is setting a new standard in delivering instant scientific proof to their customers.At the heart of this integration is Neutec's...

Read more

BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study

October 21, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, is pleased to announce the launch of an important large-mass animal bioequivalence study for its lead product, BNT23001, a proprietary sublingual Cladribine formulation for the treatment of multiple sclerosis ("MS"). This is the final animal study to generate dosing parameters for...

Read more

Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates

October 21, 2025 3:00 AM

As Europe advances toward the European Health Data Space (EHDS), a new Black Book Research regional pulse survey exposes persistent interoperability barriers stalling seamless cross-border data exchange.While interoperability readiness has improved by nine percentage points since 2023, a fraction of European hospitals report achieving full cross-border data liquidity , meaning structured, standards-based patient information can flow freely...

Read more

The Piazza Center in Austin Offers New AlloClae Treatment

October 20, 2025 2:00 PM

The Piazza Center for Plastic Surgery & Advanced Skin Care is among the first in the Austin area to offer AlloClae, an innovative, FDA-compliant injectable fat filler revolutionizing non-surgical enhancements for hips, breasts, and buttocks. This cutting-edge treatment provides a minimally invasive solution for patients seeking natural-looking volume restoration without the complexities of traditional surgery.AlloClae, is an innovative...

Read more

U.S. Olympic Athlete Ashley Hoffman Becomes Sam Brand Ambassador for Active Living With Knee Osteoarthritis

October 20, 2025 9:00 AM

Olympic athletes need the most advanced methods to perform at the highest level of sport and to recover from workouts and injuries. After competing in field hockey at the 2024 Paris Olympic Games, Ashley Hoffman turned to the sam® wearable ultrasound unit from ZetrOZ Systems to manage her knee osteoarthritis.As the latest sam® brand ambassador, Hoffman is sharing how the wearable ultrasound device helps with her knee problems."I really like to...

Read more

NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices

October 20, 2025 9:00 AM

The Initiative for Medicines, Access and Knowledge (I-MAK) released findings from a comprehensive survey of 726 American adults examining public attitudes toward prescription drug pricing and potential reforms. Conducted by Franklin & Marshall College's Center for Opinion Research in June 2025, the survey reveals unprecedented bipartisan consensus on the urgent need for prescription drug reform, with patent reform emerging as the most...

Read more

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus

October 20, 2025 8:45 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized animal model. The Company announces that NV-387 can now be made available for emergency use application in Measles patients to respond to the spreading Measles outbreaks.Having a drug to treat patients has become of paramount importance, in view of the...

Read more

Med-X to Exhibit its Nature-Cide Division at the PestWorld Conference in Orlando from October 21-24, 2025

October 20, 2025 8:31 AM

Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced its participation at PestWorld 2025, scheduled October 21-24 at the Marriott Orlando World Center in Orlando, Florida. Med-X's leadership team will present the full Nature-Cide product portfolio to pest management professionals, distributors, and industry leaders and stakeholders. Each year, the...

Read more

Stemtech Corporation Backorders Filled

October 20, 2025 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, announces core products are available for shipment after overcoming challenges with supply delivery and manufacturing. Stemtech Corporation, a Nevada USA company (OTCQB:STEK).Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "having inventory to fill orders after dealing with supply issues related to tariffs and capital constraints for some of our...

Read more

Health Impact Alliance and Connect America Announce "LifelineConnect" to Transform Senior Independence

October 20, 2025 8:00 AM

Health Impact Alliance (HIA) and Connect America today announced a Letter of Intent under which Connect America will grant HIA rights to expand the iconic Lifeline brand across North America, subject to a definitive agreement. The partnership combines Lifeline's 50-year legacy of trusted emergency response with HIA's innovative connected healthcare ecosystem to support senior independence at scale.Under the new brand LifelineConnect, the...

Read more

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

October 20, 2025 7:45 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company's footprint in the Canadian growing antibiotic sector. Doxycycline is now available to pharmacies, hospitals and healthcare providers nationwide.Doxycycline is a broad-spectrum...

Read more

HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026

October 20, 2025 7:30 AM

Investor attention at HLTH 2025 is consolidating around a focused set of AI platform categories expected to drive the next phase of health IT disruption. Black Book Research surveyed 154 past HLTH attendees and healthcare investors including those with both successful and failed investments using an investor-specific KPI framework to analyze which AI innovations are most likely to outperform in performance, delivery, and displacement...

Read more

Peer-Reviewed Journal of Clinical Psychiatry Publishes Mentavi's Online ADHD Diagnostic Evaluation Validation Study

October 20, 2025 6:00 AM

Mentavi Health announced that its landmark, real-world validation study of the Mentavi Diagnostic Evaluation has been published in the peer reviewed Journal of Clinical Psychiatry (JCP). In what is believed to be the first peer-reviewed study of its kind, an asynchronous, online evaluation matched the diagnostic accuracy of a clinician-led interview for adult ADHD. This publication provides the first peer-reviewed evidence base for a fully...

Read more

Bionic Bloom's NEI to Sponsor Cannadelic Global Summit

October 20, 2025 5:00 AM

Bionic Bloom's Neurodivergent Empowerment Institute (NEI) is proud to announce its sponsorship of the upcoming Cannadelic Global Summit, to be held November 9, 2025, at 2201 1st Ave S, St. Petersburg, FL. This premier event fuses cutting-edge psychedelic research with culture, connection, and conscious healing. Dr. Angela Fisher, founder of Bionic Bloom and Chancellor of Sacred Bloom College of Healing Arts, will deliver a TED-style keynote...

Read more

Genflow Biosciences PLC Announces Recognition of Patentability of Claims

October 20, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), the only publicly listed longevity company in Europe, is pleased to announce that its European patent (No. 22808414.1, Publication No. EP4338267) was officially published in the European Patent Office (EPO) Bulletin on 15 October 2025.The EPO has recognized the patentability of claims of Genflow's Euro-PCT application, marking a major milestone in the Company's ongoing...

Read more

Dr. Angela Fisher Wins "Best Therapist" in Creative Loafing's Best of the Bay Awards for the Second Year in a Row

October 19, 2025 8:15 PM

Bionic Bloom proudly celebrates Dr. Angela Fisher, PhD, for being named Best Therapist in Creative Loafing Tampa Bay's Best of the Bay Awards for the second consecutive year.As founder of Bionic Bloom Wellness Collective, Dr. Fisher has pioneered a new model of integrative mental-health care that blends psychotherapy, psychedelic assisted therapy, neurodivergent empowerment, and holistic wellness. Her leadership has established Bionic Bloom as...

Read more

Bionic Bloom Welcomes Abigail Hagan, MT-BC, Board-Certified Music Therapist Specializing in Neurodivergent Children

October 19, 2025 8:15 PM

Bionic Bloom, the nation's first legal psilocybin therapy and integrative mental-health clinic, proudly announces the addition of Abigail Hagan, MT-BC, to its expanding interdisciplinary team. A board-certified music therapist with extensive experience supporting neurodivergent children, Abigail brings a compassionate, creative, and evidence-informed approach to therapy.At Bionic Bloom's Neurodivergent Empowerment Institute, Abigail will lead...

Read more

Bionic Bloom Launches Dopamine Reset & Reward Center Rewire Program at the Neurodivergent Empowerment Institute

October 19, 2025 8:10 PM

Bionic Bloom's Neurodivergent Empowerment Institute (NEI) is proud to announce the launch of its newest neuroscience-based Intensive Outpatient Program (IOP): Dopamine Reset & Reward Center Rewire, running November through December 2025.This innovative, evidence-informed program helps participants retrain the brain's reward system - shifting dopamine away from overstimulation and burnout, toward sustainable motivation, focus, and joy."Our...

Read more